Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 701 to 750 of 1904

TitleReference numberPublishedLast updated
Pembrolizumab with axitinib for untreated advanced renal cell carcinomaTA650
Naldemedine for treating opioid-induced constipationTA651
Polatuzumab vedotin with rituximab and bendamustine for treating relapsed or refractory diffuse large B-cell lymphomaTA649
Transcranial magnetic stimulation for auditory hallucinationsIPG680
Neuropathic pain in adults: pharmacological management in non-specialist settingsCG173
Insect bites and stings: antimicrobial prescribingNG182
Dupilumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal)TA648
Axonics sacral neuromodulation system for treating refractory overactive bladderMTG50
Glasdegib with chemotherapy for untreated acute myeloid leukaemia (terminated appraisal)TA646
Eculizumab for treating relapsing neuromyelitis optica (terminated appraisal)TA647
Avelumab with axitinib for untreated advanced renal cell carcinomaTA645
Implantable cardiac monitors to detect atrial fibrillation after cryptogenic strokeDG41
High-sensitivity troponin tests for the early rule out of NSTEMIDG40
Anaphylaxis: assessment and referral after emergency treatmentCG134
Perioperative care in adultsNG180
Rehabilitation for adults with complex psychosisNG181
Surgical site infections: prevention and treatmentNG125
Brentuximab vedotin in combination for untreated systemic anaplastic large cell lymphomaTA641
Gilteritinib for treating relapsed or refractory acute myeloid leukaemiaTA642
Entrectinib for treating ROS1-positive advanced non-small-cell lung cancerTA643
Entrectinib for treating NTRK fusion-positive solid tumoursTA644
Deep brain stimulation for refractory epilepsy in adultsIPG678
Implanted vagus nerve stimulation for treatment-resistant depressionIPG679
Treosulfan with fludarabine for malignant disease before allogeneic stem cell transplantTA640
Transcranial magnetic stimulation for obsessive-compulsive disorderIPG676
Electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney diseaseIPG677
Artificial iris insertion for acquired aniridiaIPG674
Artificial iris insertion for congenital aniridiaIPG675
Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancerTA638
Atezolizumab with nab-paclitaxel for untreated PD-L1-positive, locally advanced or metastatic, triple-negative breast cancerTA639
Daratumumab with lenalidomide and dexamethasone for untreated multiple myeloma (terminated appraisal)TA634
Ramucirumab with erlotinib for untreated EGFR-positive metastatic non-small-cell lung cancer (terminated appraisal)TA635
Eculizumab for treating refractory myasthenia gravis (terminated appraisal)TA636
Ranibizumab for treating diabetic retinopathy (terminated appraisal)TA637
Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedureTA626
Intravascular lithotripsy for calcified coronary arteries during percutaneous coronary interventionIPG673
Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasiaMTG49
Ustekinumab for treating moderately to severely active ulcerative colitisTA633
Tests to help assess risk of acute kidney injury for people being considered for critical care admission (ARCHITECT and Alinity i Urine NGAL assays, BioPorto NGAL test and NephroCheck test)DG39
Generalised anxiety disorder and panic disorder in adults: managementCG113
Intravenous fluid therapy in children and young people in hospitalNG29
Trastuzumab emtansine for adjuvant treatment of HER2-positive early breast cancerTA632
Joint replacement (primary): hip, knee and shoulderNG157
Larotrectinib for treating NTRK fusion-positive solid tumoursTA630
Lorlatinib for previously treated ALK-positive advanced non-small-cell lung cancerTA628
Obinutuzumab with bendamustine for treating follicular lymphoma after rituximabTA629
PneuX to prevent ventilator-associated pneumoniaMTG48
Lenalidomide with rituximab for previously treated follicular lymphomaTA627
Abdominal aortic aneurysm: diagnosis and managementNG156
Tinnitus: assessment and managementNG155

Results per page

  1. 10
  2. 25
  3. 50
  4. All